BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36339630)

  • 1. Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets.
    Fu K; Zheng X; Chen Y; Wu L; Yang Z; Chen X; Song W
    Front Pharmacol; 2022; 13():1050630. PubMed ID: 36339630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for Treatment of Infected Diabetic Foot Ulcers.
    Chang M; Nguyen TT
    Acc Chem Res; 2021 Mar; 54(5):1080-1093. PubMed ID: 33596041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting MMP-9 in Diabetic Foot Ulcers.
    Jones JI; Nguyen TT; Peng Z; Chang M
    Pharmaceuticals (Basel); 2019 May; 12(2):. PubMed ID: 31121851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Matrix Metalloproteinases in Diabetic Wound Healing in relation to Photobiomodulation.
    Ayuk SM; Abrahamse H; Houreld NN
    J Diabetes Res; 2016; 2016():2897656. PubMed ID: 27314046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective MMP-9 Inhibitor (
    Peng Z; Nguyen TT; Song W; Anderson B; Wolter WR; Schroeder VA; Hesek D; Lee M; Mobashery S; Chang M
    ACS Pharmacol Transl Sci; 2021 Feb; 4(1):107-117. PubMed ID: 33615165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing.
    Muller M; Trocme C; Lardy B; Morel F; Halimi S; Benhamou PY
    Diabet Med; 2008 Apr; 25(4):419-26. PubMed ID: 18387077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.
    Lobmann R; Ambrosch A; Schultz G; Waldmann K; Schiweck S; Lehnert H
    Diabetologia; 2002 Jul; 45(7):1011-6. PubMed ID: 12136400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restructuring of the extracellular matrix in diabetic wounds and healing: A perspective.
    Chang M
    Pharmacol Res; 2016 May; 107():243-248. PubMed ID: 27033051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing diabetic wound healing: advances in electrospun scaffolds from pathogenesis to therapeutic applications.
    Jiang X; Zeng YE; Li C; Wang K; Yu DG
    Front Bioeng Biotechnol; 2024; 12():1354286. PubMed ID: 38375451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of matrix metalloproteinases on the healing of diabetic foot ulcer: A systematic review.
    Zhang WQ; Tang W; Hu SQ; Fu XL; Wu H; Shen WQ; Chen HL
    J Tissue Viability; 2023 Feb; 32(1):51-58. PubMed ID: 36513539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers.
    López-López N; González-Curiel I; Treviño-Santa Cruz MB; Rivas-Santiago B; Trujillo-Paez V; Enciso-Moreno JA; Serrano CJ
    Arch Dermatol Res; 2014 Nov; 306(9):809-21. PubMed ID: 25168880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of a Common Antibiotics Doxycycline on Non-Healing Chronic Wound.
    Xu DH; Zhu Z; Fang Y
    Curr Pharm Biotechnol; 2017; 18(5):360-364. PubMed ID: 28524000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases in wound repair (review).
    Ravanti L; Kähäri VM
    Int J Mol Med; 2000 Oct; 6(4):391-407. PubMed ID: 10998429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Foot Ulcers: A Review of Debridement Techniques.
    Sa BC; Maskan Bermudez N; Shimon SV; Kirsner RS
    Surg Technol Int; 2024 Feb; 44():. PubMed ID: 38372560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncontrolled gelatin degradation in non-healing chronic wounds.
    Trøstrup H; Holstein P; Karlsmark T; Moser C; Ågren MS
    J Wound Care; 2018 Nov; 27(11):724-734. PubMed ID: 30398935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant, Wound Healing Potential and In Silico Assessment of Naringin, Eicosane and Octacosane.
    Balachandran A; Choi SB; Beata MM; Małgorzata J; Froemming GRA; Lavilla CA; Billacura MP; Siyumbwa SN; Okechukwu PN
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of dipeptidyl peptidase 4 inhibitors on healing of chronic diabetic foot ulcers].
    Gao Y; Liang Y; Ran X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):630-633. PubMed ID: 29806355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
    Lobmann R; Zemlin C; Motzkau M; Reschke K; Lehnert H
    J Diabetes Complications; 2006; 20(5):329-35. PubMed ID: 16949521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on contemporary nanomaterial-based therapeutics for the treatment of diabetic foot ulcers (DFUs) with special reference to the Indian scenario.
    Sethuram L; Thomas J; Mukherjee A; Chandrasekaran N
    Nanoscale Adv; 2022 May; 4(11):2367-2398. PubMed ID: 36134136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.